LABNEW (LAB) fluctuates 108.8% in 24 hours: Whale accumulation drives rebound before pullback, manipulation concerns trigger sell-off
Bitget Pulse2026/05/15 22:03Volatility Overview
In the past 24 hours, LABNEW (LAB) price quickly rebounded from a low of $2.88837 to a high of $6.03102, then retraced to the current $4.50032, with an overall amplitude of 108.8%. The 24-hour trading volume surged sharply to the $206 million–$238 million range, indicating a significant increase in capital activity, and on-chain data shows a clear net inflow trend.
Brief Analysis of Abnormal Fluctuations
- Whale accumulation and net capital inflow: On-chain monitoring indicates that whales have been consistently net buying, driving the price to rebound rapidly from the low and boosting trading volume.
- Manipulation concerns trigger selling: The market has growing doubts about exchange-driven token games and insider position tightening, leading to concentrated profit-taking by holders.
- Aftermath of previous large token allocations: A recent incident where 10 new wallets withdrew around 100 million LAB (32% of circulating supply) from Bitget and distributed them OTC at a discount continues to exert short-term pressure on the price, but the main driver within 24 hours remains whale activity and sentiment shifts.
Market Opinions and Outlook
The mainstream community sentiment is cautious, with traders focusing on long liquidation risks under high funding rates. Some analysts point out that short-term volatility may continue, and advise vigilance for further pullbacks to support levels. The consensus view is that continued whale accumulation may provide rebound momentum, but manipulation concerns could still suppress upside potential. It is recommended to closely monitor large on-chain transfers and changes in derivatives positions.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring, and is for information purposes only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Nebius Q3 results exceed expectations, capital expenditure rises to $27 billion, ARR target postponed, stock falls over 14% pre-market | Earnings Report Insights
Nebius reported Q3 revenue of $981 million (a year-on-year increase of 571%) and adjusted EBITDA of $466 million, both exceeding expectations. However, the company delayed and lowered its guidance for annual recurring revenue (ARR), stating that it is no longer applicable. Additionally, it significantly raised its 2026 capital expenditure target to $27 billion, with projections to further increase to $40 billion to $45 billion in 2027. The stock price plummeted more than 14% in pre-market trading.